View Latest Medical and Pharma Bids and Tenders

Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V To Ws Allergen Extract Various Origin Excl. Injection Suspensions For Subk. Application F.d. E.g. 11/01/22 - 10/31/24

Conclusion Of Non-exclusive Discount Agreements In Accordance With §§ 130a Para. 8/130c Abs. 1 Sgb V On Drugs With The Active Ingredient Imiquimod (d06bb10) As Part Of A So-called Open-house Model.

Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V On The Active Substance Tapentadol, Atc N02ax06 For The Period 01.11.2022 - 31.10.2024

Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V On The Active Ingredient Pirfenidone, Atc L04ax05 For The Period 11/01/2022 - 10/31/2024